Hologic Inc.’s efforts to grow its 3D breast tomosynthesis business may have gotten a boost this week with positive data published in the Journal of the American Medical Association.
The addition of tomosynthesis to digital mammography decreases the tests’ recall rate and increases its cancer-detection rate, according to results...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?